The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gerozac 60 mg Capsules, Hard



McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/071/001

Main Information

Trade NameGerozac 60 mg Capsules, Hard
Active SubstancesFLUOXETINE HYDROCHLORIDE
Dosage FormCapsule, hard
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/071/001

Group Information

ATC CodeN06AB Selective serotonin reuptake inhibitors
N06AB03 fluoxetine

Status

License statusAuthorised
Licence Issued03/03/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListFluoxetine 60mg Capsules
Interchangeable List CodeIC0075-127-001
Interchangeable List DocumentPDF of Interchangeable List
« Back